{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:47:44Z","timestamp":1761518864215},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T00:00:00Z","timestamp":1191369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1245\/s10434-007-9558-6","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T13:23:45Z","timestamp":1191331425000},"page":"430-437","source":"Crossref","is-referenced-by-count":15,"title":["Is there any Prognostically Different Subgroup among Patients with Stage IIIC (Any TN3M0) Breast Carcinoma?"],"prefix":"10.1245","volume":"15","author":[{"given":"N\u00fcvit","family":"Duraker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep C.","family":"\u00c7aynak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bak\u0131r","family":"Bat\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,3]]},"reference":[{"key":"9558_CR1","volume-title":"AJCC Cancer Staging Manual","year":"2002","unstructured":"Greene FL, Page DL, Fleming ID, et al. (eds). AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002","edition":"6"},{"key":"9558_CR2","volume-title":"AJCC Cancer Staging Manual","year":"1997","unstructured":"Fleming ID, Cooper JS, Henson DE, et al. (eds). AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven; 1997","edition":"5"},{"key":"9558_CR3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/cncr.21199","volume":"104","author":"N Duraker","year":"2005","unstructured":"Duraker N, \u00c7aynak ZC. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes. Cancer 2005;104:700\u20137.","journal-title":"Cancer"},{"key":"9558_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJMoa030684","volume":"349","author":"MS Tallman","year":"2003","unstructured":"Tallman MS, Gray R, Robert NJ, et al. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer. N Engl J Med 2003;349:17\u201326","journal-title":"N Engl J Med"},{"key":"9558_CR5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1200\/JCO.2004.07.026","volume":"22","author":"AR Zander","year":"2004","unstructured":"Zander AR, Kr\u00f6ger N, Schmoor C, et al. High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. J Clin Oncol 2004;22:2273\u201383","journal-title":"J Clin Oncol"},{"key":"9558_CR6","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2005.10.202","volume":"23","author":"WP Peters","year":"2005","unstructured":"Peters WP, Rosner GL, Vredenburgh JJ, et al. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. J Clin Oncol 2005;23:2191\u2013200","journal-title":"J Clin Oncol"},{"key":"9558_CR7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/annonc\/mdi166","volume":"16","author":"RC Coombes","year":"2005","unstructured":"Coombes RC, Howell A, Emson M, et al. High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomized trial. Ann Oncol 2005;16:726\u201334","journal-title":"Ann Oncol"},{"key":"9558_CR8","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/cncr.21906","volume":"106","author":"EO Hanrahan","year":"2006","unstructured":"Hanrahan EO, Broglio K, Frye D, et al. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years. Cancer 2006;106:2327\u201336.","journal-title":"Cancer"},{"key":"9558_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMoa022794","volume":"349","author":"S Rodenhuis","year":"2003","unstructured":"Rodenhuis S, Bontenbal M, Beex LVAM, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N Engl J Med 2003;349:7\u201316","journal-title":"N Engl J Med"},{"key":"9558_CR10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0140-6736(05)67784-7","volume":"366","author":"UA Nitz","year":"2005","unstructured":"Nitz UA, Mohrmann S, Fischer J, et al. Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial. Lancet 2005;366:1935\u201344","journal-title":"Lancet"},{"key":"9558_CR11","first-page":"3425","volume":"5","author":"Y Nieto","year":"1999","unstructured":"Nieto Y, Cagnoni PJ, Shpall EJ, et al. A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant. Clin Cancer Res 1999;5:3425\u201331","journal-title":"Clin Cancer Res"},{"key":"9558_CR12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bmt.1703004","volume":"27","author":"B Bolwell","year":"2001","unstructured":"Bolwell B, Andresen S, Pohlman B, et al. Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II\/III breast cancer. Bone Marrow Transplant 2001;27:843\u20136","journal-title":"Bone Marrow Transplant"},{"key":"9558_CR13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1083-8791(01)80004-5","volume":"7","author":"A Schneeweiss","year":"2001","unstructured":"Schneeweiss A, Goerner R, Hensel M, et al. Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapy. Biol Blood Marrow Transplant 2001;7:332\u201342","journal-title":"Biol Blood Marrow Transplant"},{"key":"9558_CR14","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1078-0432.CCR-03-0536","volume":"10","author":"Y Nieto","year":"2004","unstructured":"Nieto Y, Nawaz S, Shpall EJ, Bearman SI, Murphy J, Jones RB. Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy. Clin Cancer Res 2004;10:2609\u201317","journal-title":"Clin Cancer Res"},{"key":"9558_CR15","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/1097-0142(19800615)45:12<2917::AID-CNCR2820451203>3.0.CO;2-M","volume":"45","author":"T Nemoto","year":"1980","unstructured":"Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917\u201324","journal-title":"Cancer"},{"key":"9558_CR16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher B, Bauer M, Wickerham L, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer 1983;52:1551\u20137","journal-title":"Cancer"},{"key":"9558_CR17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ejso.2006.06.005","volume":"32","author":"B Kuru","year":"2006","unstructured":"Kuru B. Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma. Eur J Surg Oncol 2006;32:1082\u20138","journal-title":"Eur J Surg Oncol"},{"key":"9558_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/ejso.2002.1239","volume":"28","author":"BCH Wal Van der","year":"2002","unstructured":"Van der Wal BCH, Butzelaar RMJM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002;28:481\u20139","journal-title":"Eur J Surg Oncol"},{"key":"9558_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2003.10.015","volume":"70","author":"M Woordeckers","year":"2004","unstructured":"Woordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 2004;70:225\u201330","journal-title":"Radiother Oncol"},{"key":"9558_CR20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-004-6276-7","volume":"91","author":"SA Joslyn","year":"2005","unstructured":"Joslyn SA, Konety BR. Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treat 2005;91:11\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"9558_CR21","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.20969","volume":"103","author":"PT Truong","year":"2005","unstructured":"Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA. The prognostic significance of the percentage of positive\/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005;103:2006\u201314.","journal-title":"Cancer"},{"key":"9558_CR22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijrobp.2005.12.014","volume":"65","author":"A Fortin","year":"2006","unstructured":"Fortin A, Dagnault A, Blondeau L, Vu TTT, Larochelle M. The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breast-conserving surgery with or without regional irradiation. Int J Radiat Oncol Biol Phys 2006;65:33\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9558_CR23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0039-6109(05)70061-X","volume":"79","author":"I Jatoi","year":"1999","unstructured":"Jatoi I. Management of the axilla in primary breast cancer. Surg Clin North Am 1999;79:1061\u201373.","journal-title":"Surg Clin North Am"},{"key":"9558_CR24","first-page":"245","volume":"180","author":"WK Ruffin","year":"1995","unstructured":"Ruffin WK, Stacey-Clear A, Younger J, Hoover HC. Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg 1995;180:245\u201351.","journal-title":"J Am Coll Surg"},{"key":"9558_CR25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1096-9098(199709)66:1<2::AID-JSO2>3.0.CO;2-8","volume":"66","author":"MP Moore","year":"1997","unstructured":"Moore MP, Kinne DW. Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol 1997;66:2\u20136.","journal-title":"J Surg Oncol"},{"key":"9558_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10434-999-0017-4","volume":"6","author":"M Morrow","year":"1999","unstructured":"Morrow M. A survival benefit from axillary dissection: was Halsted correct? Ann Surg Oncol 1999;6:17\u20138","journal-title":"Ann Surg Oncol"},{"key":"9558_CR27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1245\/ASO.2003.10.917","volume":"10","author":"KM McMasters","year":"2003","unstructured":"McMasters KM. The eternally enigmatic axilla: further controversy about axillary lymph nodes in breast cancer. Ann Surg Oncol 2003;10:1128\u201330.","journal-title":"Ann Surg Oncol"},{"key":"9558_CR28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdi060","volume":"16","author":"A Luini","year":"2005","unstructured":"Luini A, Gatti G, Ballardini B, et al. Development of axillary surgery in breast cancer. Ann Oncol 2005;16:259\u201362.","journal-title":"Ann Oncol"},{"key":"9558_CR29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","volume":"7","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet Oncol 2006;7:983\u201390.","journal-title":"Lancet Oncol"},{"key":"9558_CR30","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703\u201320.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9558-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-007-9558-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9558-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:26:45Z","timestamp":1572971205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-007-9558-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["9558"],"URL":"https:\/\/doi.org\/10.1245\/s10434-007-9558-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,3]]}}}